[go: up one dir, main page]

MX2017008274A - Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados. - Google Patents

Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados.

Info

Publication number
MX2017008274A
MX2017008274A MX2017008274A MX2017008274A MX2017008274A MX 2017008274 A MX2017008274 A MX 2017008274A MX 2017008274 A MX2017008274 A MX 2017008274A MX 2017008274 A MX2017008274 A MX 2017008274A MX 2017008274 A MX2017008274 A MX 2017008274A
Authority
MX
Mexico
Prior art keywords
composition
weight
stability
fatty acids
polyunsaturated omega
Prior art date
Application number
MX2017008274A
Other languages
English (en)
Other versions
MX391057B (es
Inventor
Schwarm Michael
Knaup Günter
Latinovic Milan
Original Assignee
Evonik Degussa Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52344990&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017008274(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evonik Degussa Gmbh filed Critical Evonik Degussa Gmbh
Publication of MX2017008274A publication Critical patent/MX2017008274A/es
Publication of MX391057B publication Critical patent/MX391057B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0085—Substances of natural origin of unknown constitution, f.i. plant extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1882—Polyunsaturated fatty acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados La presente invención se refiere a procesos para aumentar la estabilidad de composiciones que comprenden ácidos grasos omega-6 poliinsaturados contra la oxidación. Los procesos comprenden las siguientes etapas: (i) proporcionar una composición de partida que comprende al menos un componente ácido graso omega-6 poliinsaturado; (ii) proporcionar una composición de lisina; (iii) mezclar soluciones acuosas, acuoso-alcohólicas o alcohólicas de composición de partida y composición de lisina, y someter posteriormente la mezcla resultante a condiciones de secado por pulverización, formando así una composición de producto sólido que comprende al menos una sal de un catión derivado de lisina con un anión derivado a partir de un ácido graso omega-6 poliinsaturado; la composición del producto que presenta un contenido de disolvente SC seleccionado entre los siguientes: SC <5 % en peso, SC <3 % en peso, SC <1 % en peso, SC <0.5 % en peso. Las composiciones obtenibles mediante tales procesos de secado por pulverización y el uso de tales composiciones para la fabricación de productos alimenticios, nutricionales y farmacéuticos están comprendidos además por la presente invención.
MX2017008274A 2014-12-23 2015-12-17 Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados. MX391057B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14199976 2014-12-23
PCT/EP2015/080293 WO2016102316A1 (en) 2014-12-23 2015-12-17 Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids

Publications (2)

Publication Number Publication Date
MX2017008274A true MX2017008274A (es) 2017-10-02
MX391057B MX391057B (es) 2025-03-21

Family

ID=52344990

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017008274A MX391057B (es) 2014-12-23 2015-12-17 Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados.

Country Status (24)

Country Link
US (1) US20170367394A1 (es)
EP (1) EP3236783B1 (es)
JP (1) JP6714000B2 (es)
KR (1) KR20170094789A (es)
CN (1) CN107105693B (es)
AU (1) AU2015371457B2 (es)
BR (1) BR112017013445B1 (es)
CA (1) CA2969157C (es)
CL (1) CL2017001613A1 (es)
CO (1) CO2017005849A2 (es)
DK (1) DK3236783T3 (es)
ES (1) ES2776393T3 (es)
IL (1) IL252482B (es)
MX (1) MX391057B (es)
MY (1) MY190506A (es)
PE (1) PE20171082A1 (es)
PH (1) PH12017501144B1 (es)
PL (1) PL3236783T3 (es)
RU (1) RU2706072C2 (es)
SA (1) SA517381762B1 (es)
SG (1) SG11201704399RA (es)
TW (1) TWI693893B (es)
WO (1) WO2016102316A1 (es)
ZA (1) ZA201704821B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11622952B2 (en) 2017-08-15 2023-04-11 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
WO2019093708A1 (ko) * 2017-11-08 2019-05-16 김승수 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법
EP3804699A1 (en) 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
US20220287345A1 (en) * 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
US20220280388A1 (en) 2019-08-08 2022-09-08 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
MX2022001570A (es) * 2019-08-08 2022-03-02 Evonik Operations Gmbh Proceso de flujo descendente para la produccion de sales de acidos grasos poliinsaturados.
CA3146542A1 (en) 2019-08-08 2021-02-11 Ashish Guha Method of preparing a solid dosage form and a lubricant
EP4097201A4 (en) * 2020-01-30 2024-01-24 Silicycle Inc. METHOD FOR PREPARING A SOLID FORM OF BASIC AMINO ACID SALTS OF POLYUNSATURATED FATTY ACIDS
US20230037453A1 (en) 2020-04-01 2023-02-09 Evonik Operations Gmbh Preparation for use as vasorelaxant
WO2021197971A1 (en) 2020-04-01 2021-10-07 Evonik Operations Gmbh Preparation for use as antioxidant
CN111635306B (zh) * 2020-06-12 2022-09-27 上海海益环保科技有限公司 一种芥酸复合稳定剂及制备稳定芥酸的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
EP1564278B1 (en) * 2002-11-22 2018-01-10 Nippon Suisan Kaisha, Ltd. Composition containing organic substance having double bond with improved oxidation stability
WO2004112777A1 (ja) * 2003-06-20 2004-12-29 Mochida Pharmaceutical Co., Ltd. 下肢静脈瘤予防・治療用組成物
US20080311255A1 (en) * 2005-02-02 2008-12-18 Dsm Ip Assets B.V. Powder Compositions
US20140199313A1 (en) * 2005-03-02 2014-07-17 Metanomics Gmbh Process for the Production of Fine Chemicals
NZ573327A (en) * 2006-06-05 2012-07-27 Ocean Nutrition Canada Ltd Microcapsules with improved shells
US20080026109A1 (en) * 2006-06-29 2008-01-31 Martek Biosciences Corporation Sweetened Oil Compositions and Methods of Making
KR20150126977A (ko) * 2007-11-01 2015-11-13 엔지모테크 리미티드 유아 영양을 위한 지질 혼합물
US8609138B2 (en) * 2010-06-30 2013-12-17 Mochida Pharmaceutical Co., Ltd. ω3 fatty acid compound preparation

Also Published As

Publication number Publication date
RU2706072C2 (ru) 2019-11-13
DK3236783T3 (da) 2020-04-27
IL252482A0 (en) 2017-07-31
CA2969157C (en) 2024-05-28
ZA201704821B (en) 2019-06-26
AU2015371457A1 (en) 2017-06-22
SA517381762B1 (ar) 2020-10-27
PH12017501144B1 (en) 2024-02-21
RU2017125963A (ru) 2019-01-24
JP6714000B2 (ja) 2020-06-24
MY190506A (en) 2022-04-26
TWI693893B (zh) 2020-05-21
NZ732380A (en) 2024-03-22
PH12017501144A1 (en) 2018-03-05
PL3236783T3 (pl) 2020-06-15
RU2017125963A3 (es) 2019-06-18
CN107105693B (zh) 2021-04-02
WO2016102316A1 (en) 2016-06-30
KR20170094789A (ko) 2017-08-21
CA2969157A1 (en) 2016-06-30
US20170367394A1 (en) 2017-12-28
PE20171082A1 (es) 2017-08-03
CL2017001613A1 (es) 2018-01-12
EP3236783A1 (en) 2017-11-01
MX391057B (es) 2025-03-21
SG11201704399RA (en) 2017-07-28
CO2017005849A2 (es) 2017-09-20
BR112017013445A2 (pt) 2018-06-26
JP2018501790A (ja) 2018-01-25
TW201639463A (zh) 2016-11-16
CN107105693A (zh) 2017-08-29
EP3236783B1 (en) 2020-02-05
ES2776393T3 (es) 2020-07-30
AU2015371457B2 (en) 2020-04-23
BR112017013445B1 (pt) 2021-11-23
IL252482B (en) 2021-08-31

Similar Documents

Publication Publication Date Title
CO2017005847A2 (es) Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados
CO2017005849A2 (es) Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados
CY1120314T1 (el) Ζωοτροφη και μια διαδικασια για την παρασκευη της
NZ747847A (en) Lipid compositions
BR112018074009A2 (pt) método para preparar uma composição compreendendo sais de ácidos graxos ômega-3
BR112017019749A2 (pt) processo de emulsificação em duas etapas para preparar fórmula para lactentes
MX347573B (es) Composiciones y metodos para incrementar la estabilidad de aditivos para productos alimenticios.
WO2015145389A3 (en) Effect of lipophilic nutrients on diabetic eye diseases
WO2015011724A3 (en) A novel omega -3 fatty acid composition with a plant extract
BR112018001164A2 (pt) composto de fórmula geral, composição farmacêutica e método para o tratamento de uma doença cardiovascular
BR112014024523A2 (pt) sistema de gordura de panificação
MX2017002231A (es) Composicion de grasa comestible.
BR112014032478A2 (pt) nanogel compreendendo ingredientes ativos solúveis em água
PH12021551857A1 (en) Antioxidant composition comprising quercetagetin and gallic acid
PE20170250A1 (es) Composiciones estructuradas de grasa vegetal, proceso para obtener dicha composicion estructurada de grasas, uso de la composicion estructurada de grasas en la preparacion de una composicion cosmetica, composicion cosmetica y producto que comprende dicha composicion estructurada de grasas
PE20221451A1 (es) Producto alimenticio en polvo, semi terminado, basado en alimentos vegetales y un proceso para la produccion del mismo
EA201692398A1 (ru) Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол
BR112012026925A2 (pt) formulações dietéticas de liberação lenta.
AR097148A1 (es) Composición alimenticia para rumiantes y método para prepararla
CL2017002828A1 (es) Composición para tratamiento de estrés oxidativo y enfermedad cardiovascular
NZ732380B2 (en) Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids
PH12014502817B1 (en) Compounds from the fruits of acrocomia crispa and acrocomia aculeata for use against oxidative stress and inflammation
AR097142A1 (es) Composición alimenticia líquida para rumiantes y métodos para prepararla
MX348893B (es) Composicion blanqueadora.
NZ732378B2 (en) Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids